LEITAT at IMI 2 Open Info Day 2014 – Brussels
30 set. 14
Leitat is attending the IMI2 Open Info day in Brussels and taking note of every novelty that the new edition
Leitat is attending the IMI2 Open Info day in Brussels and taking note of every novelty that the new edition
LEITAT attended the first meeting of Vision 2020 Health Cluster at KU Leuven. The 2-days event aimed at discussing priorities
According to the new release of Health-EU newsletter, since March the Commission has invested more than 11.9 million Euros in
TTPPP Application of the Transmembrane Therapeutic Protein Production Platform (TTPPP) to an innovative approach for the Treatment of Cancer or
NEQAM Development and Application of new Chemometric Strategies for Metabolomic Analysis ABSTRACT NEQAM project aims at the development, assessment and
ACINETOCLINIC Transition to Clinical Investigation Phase for Licencing of the First Vaccine Against Drug Resistent Acinetobacter Baumannii ABSTRACT Vaccines against
IDP4MM Development of drugs in new therapeutic IDP targets for the treatment of multiple myeloma ABSTRACT This project is part
TOXAB Development of Novel, Safe and Affordable Cytotoxic Antibodies for the Treatment of Cancer ABSTRACT The main objective of the
NUEVAS DIANAS Discovery and combination of new treatments for cancer treatment based on the modulation of epigenetic targets and adenosine
MICROALMABS Validation of a New Platform for Production of Therapeutic Monoclonal Antibodies with Microalgae ABSTRACT The objective of the present
METASTASIS Anti-tumor and anti-metastasis activity of monoclonal antibodies in animal models of human cancers ABSTRACT The limited effectiveness of approved
LEITAT Attends IMI Stakeholder Forum 2014 in Brussels LEITAT is attending the IMI Stakeholder Forum 2014 in Brussels. The IMI
LEITAT, as a member of VISION2020, was presented during the H2020 Information Session dedicated to entrepreneurs. The meeting was hosted
The 24 Month progress meeting of RESTORATION EU Consortium was hosted by JRI Orthopaedics in Sheffield – UK. The Consortium
The Innovative Medicines Initiative (IMI) enters its second phase with a €3.3 billion budget and the ambitious goal of fast-tracking
This year’s the Annual Event of ETP-Nanomedicine is hosted by CIC NanoGUNE, the Spanish nano science cooperative research centre in
Tel. (+34) 937 882 300
